Year in review 2009: Critical Care - nephrology

Ricci, Zaccaria; Ronco, Claudio

doi:10.1186/cc9277

Cited by 3 publications

(2 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Third, we enrolled AKIN stage 3 acute cardiogenic shock patients only. It is possible that early-stage AKI patients requiring CRRT may receive a greater survival benefit from early dialysis [30,31]. …”

Section: Discussionmentioning

confidence: 99%

Early Continuous Renal Replacement Therapy in Cardiogenic Shock Patients with Severe Acute Kidney Injury Undergoing Extracorporeal Membrane Oxygenation

Lin¹,

Lin²,

Lin

et al. 2014

Cardiorenal Med

View full text Add to dashboard Cite

Background: Continuous renal replacement therapy (CRRT) may benefit patients requiring extracorporeal membrane oxygenation (ECMO). However, the clinical benefits and timing of CRRT have not been fully elucidated for these patients. Methods: This study was conducted retrospectively at the Taipei Medical University Hospital between January 2008 and December 2010. We included patients who had Acute Kidney Injury Network (AKIN) stage 3 disease at the initiation of ECMO and subsequently underwent CRRT. We excluded patients aged <18 years or those who were chronic dialysis patients. Early dialysis was defined as receiving CRRT <24 h after the initiation of ECMO. The primary outcome was mortality before weaning from ECMO. Results: The median age of the 15 patients included in the study was 72 years. The median interval between ECMO and CRRT was 16 h. No significant difference in survival was observed between the early- and late-dialysis patients (p = 0.58, log-rank test). However, a trend toward a shorter mean duration of ECMO therapy was observed in the early-dialysis patients (124 vs. 169 h, p = 0.16). The median follow-up glomerular filtration rate for the survivors was 38.9 ml/min/1.73 m². Conclusion: No survival benefit is conferred by the use of CRRT within 24 h after initiating ECMO in patients with severe acute kidney injury according to AKIN criteria. © 2014 S. Karger AG, Basel

show abstract

Section: Discussionmentioning

confidence: 99%

Early Continuous Renal Replacement Therapy in Cardiogenic Shock Patients with Severe Acute Kidney Injury Undergoing Extracorporeal Membrane Oxygenation

Lin¹,

Lin²,

Lin

et al. 2014

Cardiorenal Med

View full text Add to dashboard Cite

show abstract

“…In the third category, articles using cystatin C as an early marker of ARF were examined. 55 Shlipak et al performed a meta-analysis of 16 studies (with 93710 participants) for whom standardized measurements of serum creatinine and cystatin C were available. They concluded that the use of cystatin C alone or in combination with creatinine strengthens the association between the GFR and the risks of death and end stage renal disease across diverse populations.…”

Section: Review Of Some Studies Examining Cystatin C As a Marker Of Rmentioning

confidence: 99%